USEFULNESS OF A SMARTPHONE APP IN REDUCING STROKE CODE WORKFLOW METRICS IN A COMPREHENSIVE STROKE CENTER. A PILOT STUDY (ID 1115)

Presentation Topic
AS35 TECHNOLOGY INNOVATIONS: ROBOTS, VIRTUAL REALITY, ARTIFICIAL INTELLIGENCE AND MORE
Presenter
Authors
Е-Poster Audio MP3

Abstract

Background And Aims

Mobile apps allow sharing of clinical and imaging data in the emergency setting and may help streamline workflow in acute stroke management. We aimed to test the utility of the app JOIN ® in reducing time to treatment.

Methods

abstract esoc.pngPilot observational study including stroke patients with an activation of a stroke-code from June 2019 to March 2020. JOIN´s server was installed within the hospital network and the app in the smartphones of the stroke team on duty (neurologist, neuro-radiologist, interventional radiologist). The system allows uploading of clinical data, workflow timestamps and anonymized DICOM, which are live streamed to the stroke team. Patients were registered in JOIN at the discretion of the neurologist upon stroke-code activation. Times from: door to CT (D-CT), CT to needle if iv thrombolysis (CT-N), CT to groin puncture if thrombectomy (CT-GP), door to needle (D-N) and door to groin puncture (D-GP) were compared between patients with and without JOIN activation.

Results

There were 282 stroke-code activations; 111 (39%) had any data in JOIN and 64 (58%) the arrival timestamp. 73 patients (26%) underwent IVT and 76 (27%) MT. JOIN-activated patients had shorter D-CT [17 (11) vs 21.5 (17) minutes, p=.006], CT-N [20 (14) vs 31.5(32) minutes, p=.042], and D-N [36 (17) vs 51(28) minutes, p=.035], [median (IQR)]. Differences were not significant regarding CT-GP [77 (36) vs 90 (70), p=.41] nor D-GP [93 (42) vs 93 (57), p=.83].

Conclusions

The use of JOIN improves stroke-code workflow metrics. A validation study with a multicentric design is deserved.

Trial Registration Number

NA

Hide

Е-Poster Audio MP3

Hide

Previous ePoster
IMPROVED CEREBRAL MICROBLEED DETECTION IN MAGNETIC RESONANCE IMAGES USING A MULTI-SCALE 3D CONVOLUTIONAL NEURAL NETWORK (ID 1074)

Next ePosters
BRAIN CT REGISTRATION USING HYBRID SUPERVISED CONVOLUTIONAL NEURAL NETWORK: FEASIBILITY AND RELIABILITY (ID 1570)
CITICOLINE IN ACUTE ISCHEMIC STROKE: A RANDOMIZED CONTROLLED TRIAL (CAISR) (ID 356)
EFFICACY AND SAFETY OF CEREBROLYSIN AFTER FUTILE RECANALISATION THERAPY IN PATIENTS WITH SEVERE STROKE (ID 1065)
ENDOVASCULAR MECHANICAL THROMBECTOMY WITHIN 6 TO 24 HOURS IN ELIGIBLE ACUTE ISCHEMIC STROKE PATIENTS – A REAL WORLD EXPERIENCE (ID 1212)
TREATMENT OF ACUTE ISCHEMIC STROKE DUE TO LARGE VESSEL OCCLUSION WITH COVID-19 EXPERIENCE OF TURKISH NEUROINTERVENTIONAL GROUP (ID 1424)
THROMBOLYSIS IN WAKE-UP STROKE BASED ON MRI-MISMATCH (ID 1537)
A CASE-CONTROL STUDY COMPARING THE EFFICACY OF THROMBECTOMY VERSUS COMBINED THERAPY OF THROMBECTOMY AND THROMBOLYSIS FOR COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE (ID 1596)
THYROID HORMONE DECREASING AFTER MECHANICAL THROMBECTOMY (ID 202)
PREDICTORS OF POOR OUTCOME AFTER ENDOVASCULAR REPERFUSION IN THE EARLY TIME WINDOW (ID 479)
ENDOVASCULAR TREATMENT FOR THE PATIENTS WITH ACUTE ISCHEMIC STROKE IN THE BEYOND 6-HOUR: TIME WINDOW VERSUS TISSUE WINDOW (ID 522)